Stocktoria
REGENERON PHARMACEUTICALS, INC. REGN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1991-04-02
REGENERON PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% |
| Net margin | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% |
| Return on assets | 11.1% | 11.7% | 12.0% | 14.9% | 31.7% |
| Return on equity | 14.4% | 15.0% | 15.2% | 19.1% | 43.0% |
| Debt / equity | 0.06× | 0.07× | 0.08× | 0.09× | 0.11× |
| Current ratio | 4.13 | 4.73 | 5.69 | 5.06 | 3.56 |
| Revenue growth | 1.0% | 8.3% | 7.8% | -24.3% | 89.1% |
Source: SEC EDGAR filings · CIK 0000872589 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.